# Issue 16 S1 implementation

Gate: implementation -> code review -> fix -> re-review -> accepted slice commit.
Scope: analysis rule lifecycle, laboratory-owned method catalog, migrations 0019/0020, public seam tests. No scientific defaults; all test policies live in isolated test database only.

Red/green: missing HealthRules import -> 1 passed; missing update -> 2 passed; concurrent overlapping activation returned two ACTIVE -> conflict guard -> 3 passed. Strict revision False was accepted -> validator -> 16 passed. Placeholder/inactive method regression -> 17 passed. One test import typo AuthError corrected to actual IdentityError (not production defect evidence).

Review: docs/reviews/code-review-20260913-151306.md. Timestamp-ordered event ties were nondeterministic; now order by retained revision. Guard migrated separately in 0020 because 0019 had already run on isolated test DB; no rewrite of an applied migration. Activation is one UPDATE, compatible with guard.

Validation: isolated dga-issue16-test, actual PostgreSQL. 63 passed for rules/trends/lab configuration/architecture before final added method regression; final rule suite 17 passed. Migration upgrade through 0020 succeeded; git diff --check passed. Two pre-existing Starlette deprecation warnings only.

Docs decision: retain work-unit evidence; public HTTP/UI and domain usage documentation covered by S2/S3. Residual risks: HTTP/health aggregation/browser not implemented yet, covered by later approved S2/S3. Destructive downgrade with retained evidence intentionally refused; no acceptance DB used. No unclassified residual risk.

Decision: S1 pass. Next entry point: implementation S2. No push/merge.
